Health Care
Intuitive Surgical delivered robust Q2 FY2026 results, with double-digit revenue and earnings growth propelled by da Vinci 5 adoption and higher procedure volumes, while navigating tariff and regulatory challenges.
Key risk: Third-Party Remanufactured Instruments and Unauthorized Service
Regulatory clearances for third-party remanufactured instruments and unauthorized service providers could erode Intuitive’s recurring revenue from instruments and accessories, pose safety risks, and damage its reputation. The company specifically flagged this as a threat to its high-margin consumables business.
Other Health Care Equipment companies